Please use this identifier to cite or link to this item:
http://148.72.244.84/xmlui/handle/xmlui/4925
Title: | The Investigation Of The Role Of Il-1b,Il-6,Il-10 For Patients With Irritable Bowel Syndrome |
Authors: | Abbas A.Frhan Mohamed A.Salah Malak .F.Mehdi |
Keywords: | IBS,IL-1B, IL-6,IL10. |
Issue Date: | 2017 |
Publisher: | university of Diyala |
Citation: | http://dx.doi.org/10.24237/djps.1302.234C |
Abstract: | The present study aimed to evaluate the role of interlukines of patients with irritable bowel syndrome in Diyala province, the study was conducted in Baquba teaching hospital laboratories in the province of Diyala during the period than time period 2015/10/1 to to2016/5/1Were collected (80)a sample of patients with irritable bowel syndrome after diagnosis by a doctor specialist in advisory clinic in Baquba Teaching Hospital, according to the criteria adopted by the World Health Organization for the diagnosis of irritable bowel syndrome wasThe number of males (26) by (32.5%) and the number of females (54) and the proportion of (67.5%)) within the age range (75-18 years), and collected (16) samples from healthy people apparently were collected as a control and the number of males (11 ) by (68.75%) and the number of females( 5) and percentage (31.25%) within the range of my age (55-33 )years old. . the results showed high IL-1B high level of in patients with irritable bowel syndrome (1436.9 ± 1015.9) ml / pg compared to healthy control group(120.2 ±9.9) pg / ml. The results of the current study showed higher IL-6 in patients (176.356± 117.537) pg/ ml compared to the control group (4.2± 12.5) pg / ml.As for the level of IL-10, the results showed low level of IL-10 in patients with irritable bowel syndrome (15.4 ± 40.0) ml / pg compared to the healthy control group (165.647 ± 85.438) pg / ml. |
URI: | http://148.72.244.84:8080/xmlui/handle/xmlui/4925 |
ISSN: | 2222-8373 |
Appears in Collections: | مجلة ديالى للعلوم الاكاديمية / Academic Science Journal (Acad. Sci. J.) |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.